{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:15:19Z","timestamp":1786976119702,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd012853","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T00:00:00Z","timestamp":1541635200000}}],"reference-count":46,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012853.pub2","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T11:16:17Z","timestamp":1541675777000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cannabis for the treatment of Crohn's disease"],"prefix":"10.1002","volume":"2019","author":[{"given":"Tahir S","family":"Kafil","sequence":"first","affiliation":[{"name":"University of Western Ontario; Department of Medicine; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran M","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K","family":"MacDonald","sequence":"additional","affiliation":[{"name":"University of Western Ontario; Department of Medicine; London ON Canada"},{"name":"Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Chande","sequence":"additional","affiliation":[{"name":"London Health Sciences Centre - Victoria Hospital; Room E6-321A 800 Commissioners Road East London ON Canada N6A 5W9"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,11,8]]},"reference":[{"key":"10.1002\/14651858.CD012853.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"S780","DOI":"10.1016\/S0016-5085(12)63026-1","article-title":"Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease","volume":"1","author":"Naftali","year":"2012","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD012853.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cgh.2013.04.034","article-title":"Cannabis induces a clinical response in patients with Crohn\u2019s disease: a prospective placebo-controlled study","volume":"11","author":"Naftali","year":"2013","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/S0016-5085(13)60641-1","article-title":"Cannabidiol treatment does not effect active Crohn's disease","volume":"1","author":"Naftali","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1615-20","DOI":"10.1007\/s10620-017-4540-z","article-title":"Low-dose cannabidiol is safe but not effective in the treatment for Crohn\u2019s Disease, a randomized controlled trial","volume":"62","author":"Naftali","year":"2017","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0005|cit5","unstructured":"Naftali T Schlieder LBL Konikoff FM The effect of cannabis on Crohn's Disease patients International Association of Cannabis Medicine (IACM) 2017"},{"issue":"Supplement1","key":"10.1002\/14651858.CD012853.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/S1873-9946(13)60379-7","article-title":"Tetrahydrocannabinol (THC) induces clinical and biochemical improvement with a steroid sparing effect in active inflammatory bowel disease","volume":"7","author":"Naftali","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0007|cit7","unstructured":"NCT03467620 Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease clinicaltrials.gov\/ct2\/show\/NCT03467620"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1136\/bmj.e536","article-title":"Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis","volume":"344","author":"Asbridge","year":"2012","journal-title":"BMJ"},{"issue":"19","key":"10.1002\/14651858.CD012853.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1002\/(SICI)1097-0258(19991015)18:19<2593::AID-SIM392>3.0.CO;2-T","article-title":"Examining the minimum important difference","volume":"18","author":"Brant","year":"1999","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"340-6","DOI":"10.1139\/y98-021","article-title":"Evidence that cannabinoid-induced inhibition of electrically evoked contractions of the myenteric plexus - longitudinal muscle preparation of guinea-pig small intestine can be modulated by Ca2+ and cAMP","volume":"76","author":"Coutts","year":"1998","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD012853.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1542-3565(04)00121-1","article-title":"5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion","volume":"2","author":"Feagan","year":"2004","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD012853.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1503\/cmaj.130267","article-title":"Marijuana is not a prescription medicine","volume":"185","author":"Fletcher","year":"2013","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0014|cit14","article-title":"Chapter 295: Inflammatory Bowel Disease","volume-title":"Harrison\u2019s Principles of Internal Medicine","author":"Friedman","year":"2012"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1844-52","DOI":"10.1007\/s10620-016-4090-9","article-title":"Cannabis abuse is increasing and associated with increased emergency department utilization in gastroenterology patients","volume":"61","author":"Gubatan","year":"2016","journal-title":"Digestive Diseases and Sciences"},{"issue":"7650","key":"10.1002\/14651858.CD012853.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"924-6","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/STROKEAHA.115.008680","article-title":"Cannabis and stroke - systematic appraisal of case reports","volume":"46","author":"Hackam","year":"2015","journal-title":"Stroke"},{"issue":"12","key":"10.1002\/14651858.CD012853.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/nmo.12931","article-title":"The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease","volume":"28","author":"Hasenoehrl","year":"2016","journal-title":"Journal of Neurogastroenterology and Motility"},{"issue":"13","key":"10.1002\/14651858.CD012853.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.3748\/wjg.v20.i13.3663","article-title":"Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: A review","volume":"20","author":"Hauser","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0020|cit20","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Higgins","year":"2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0021|cit21","article-title":"Chapter 16: Special topics in statistics","volume-title":"Cochrane Handbook for Systematic Reviewsof Interventions Version 5.1.0 (updated March 2011)","author":"Higgins","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"24","key":"10.1002\/14651858.CD012853.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1001\/jama.2015.6199","article-title":"Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review","volume":"313","author":"Hill","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD012853.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0016-5085(94)90585-1","article-title":"Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group","volume":"106","author":"Irvine","year":"1994","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012853.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ibd.20301","article-title":"Quality of life of patients with ulcerative colitis: past, present, and future","volume":"14","author":"Irvine","year":"2008","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"921-31","DOI":"10.1111\/j.1365-2036.2005.02424.x","article-title":"Review article: smoking cessation as primary therapy to modify the course of Crohn\u2019s disease","volume":"21","author":"Johnson","year":"2005","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11481-005-9007-x","article-title":"Cannabinoid-Induced immune suppression and modulation of antigen-presenting cells","volume":"1","author":"Klein","year":"2006","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000332079","article-title":"Impact of cannabis treatment on the quality of life, weight and clinical disease activity in Inflammatory Bowel Disease patients: A pilot prospective study","volume":"85","author":"Lahat","year":"2012","journal-title":"Digestion"},{"issue":"10","key":"10.1002\/14651858.CD012853.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/MEG.0b013e328349bb4c","article-title":"Cannabis use amongst patients with inflammatory bowel disease","volume":"23","author":"Lal","year":"2011","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD012853.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ecco-jcc\/jju007","article-title":"Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases","volume":"9","author":"Langhorst","year":"2015","journal-title":"Journal of Crohn's and Colitis"},{"issue":"9","key":"10.1002\/14651858.CD012853.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"e6893","DOI":"10.1371\/journal.pone.0006893","article-title":"Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue","volume":"4","author":"Marquez","year":"2009","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1002\/14651858.CD012853.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI200419465","article-title":"The endogenous cannabinoid system protects against colonic inflammation","volume":"113","author":"Massa","year":"2004","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"227-34","DOI":"10.1053\/gast.2002.34242","article-title":"Endocannabinoids as physiological regulators of colonic propulsion in mice","volume":"123","author":"Pinto","year":"2002","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD012853.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cpr.2011.12.002","article-title":"Tobacco and marijuana use among adolescents and young adults: A systematic review of their co-use","volume":"32","author":"Ramo","year":"2012","journal-title":"Clinical Psychology Review"},{"issue":"5","key":"10.1002\/14651858.CD012853.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2036.2004.1873.x","article-title":"Quality of life in patients with established inflammatory bowel disease: a UK general practice survey","volume":"19","author":"Rubin","year":"2004","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD012853.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"281-8","DOI":"10.1093\/ntr\/ntv093","article-title":"Differences in tobacco product use among past month adult marijuana users and nonusers: Findings from the 2003-2012 national survey on drug use and health","volume":"18","author":"Schauer","year":"2016","journal-title":"Nicotine and Tobacco Research"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.addbeh.2016.09.001","article-title":"Marijuana and tobacco co-administration in blunts, spliffs, and mulled cigarettes: A systematic literature review","volume":"64","author":"Schauer","year":"2017","journal-title":"Addictive Behaviors"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0037|cit37","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Sch\u00fcnemann","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD012853.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"256-67","DOI":"10.1016\/j.taap.2011.11.005","article-title":"Cannabinoids Receptor-2 (CB2) agonist ameliorates colitis inIL-10\u2212\/\u2212 mice by attenuating the activation of T cells and promoting their apoptosis","volume":"258","author":"Singh","year":"2012","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012853.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"472-80","DOI":"10.1097\/01.MIB.0000440982.79036.d6","article-title":"Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn\u2019s disease","volume":"20","author":"Storr","year":"2014","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1758-5996-2-5","article-title":"The multiple functions of the endocannabinoid system: a focus on the regulation of food intake","volume":"2","author":"Tibirica","year":"2010","journal-title":"Diabetology and Metabolic Syndrome"},{"issue":"3","key":"10.1002\/14651858.CD012853.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1586\/egh.13.4","article-title":"Psychological factors and stress in inflammatory bowel disease","volume":"7","author":"Triantafillidis","year":"2013","journal-title":"Expert Review of Gastroenterology and Hepatology"},{"issue":"30","key":"10.1002\/14651858.CD012853.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"10331-7","DOI":"10.1523\/JNEUROSCI.4507-11.2012","article-title":"Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility","volume":"32","author":"Vianna","year":"2012","journal-title":"Journal of Neuroscience"},{"issue":"1","key":"10.1002\/14651858.CD012853.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00482-015-0087-0","article-title":"Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review","volume":"30","author":"Volz","year":"2016","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD012853.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.drugalcdep.2015.08.035","article-title":"Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis","volume":"156","author":"Weiss","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"24","key":"10.1002\/14651858.CD012853.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD012853.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.gastro.2005.05.026","article-title":"Differential expression of cannabinoid receptors in the human colon: Cannabinoids promote epithelial wound healing","volume":"129","author":"Wright","year":"2005","journal-title":"Gastroenterology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012853.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T03:20:48Z","timestamp":1677468048000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012853.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,8]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012853.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,8]]}}}